Help us improve our site.
Bisphosphonate therapy for prostate cancer
Bisphosphonate therapy is a systemic therapy that may be used in the treatment of prostate cancer to strengthen bone.
Bisphosphonate therapy may be used:
- to relieve bone pain or to prevent fractures in advanced hormone-refractory prostate cancer (palliative therapy)
- to prevent osteoporosis in men receiving hormonal therapy
Bisphosphonates are used in combination with other standard treatments for hormone-refractory prostate cancer.
The bisphosphonate used to treat hormone-refractory prostate cancer is:
- zoledronic acid (Zometa)
- Zoledronic acid is used to treat men who have little or no pain from bone metastases.
- This drug is effective in reducing the number of skeletal related events, including bone fractures and the need for radiation to bone metastases.
- This drug also reduces pain related to bone metastases.
- The drug has a number of side effects, and men should be informed of the risks and benefits of taking zoledronic acid.
I was staying in St. John’s all by my lonesome because my wife was too sick to travel with me. Daffodil Place was my lifeline.
Advocating for cancer patients
Our staff and volunteers meet with elected officials from local, provincial and national governments to persuade them to make the fight against cancer one of their top priorities.